Webpage

This webpage outlines the importance of disaster preparedness for people with HIV. Natural disasters—such as hurricanes, tornadoes, tsunamis, and wildfires—can displace anyone, disrupting access to critical HIV medicines and care. It emphasizes the need for individuals with HIV to plan ahead to maintain treatment continuity, protect their health, and reduce the risk of transmission, including steps to connect with new healthcare providers if displaced.

This webpage explain how LGBTQ+ young people are not inherently prone to suicide risk because of their sexual orientation or gender identity but rather placed at higher risk because of how they are mistreated and stigmatized in society.

This webpage explains that persistent high-risk HPV—especially type 16—is a leading cause of oropharyngeal cancer, accounting for around 70% of U.S. throat cancers, and highlights prevention strategies like vaccination, sexual health practices, and regular screenings.

This webpage explains common causes—such as STIs, infections, or irritation—along with symptoms, diagnosis, and treatment options. It emphasizes the importance of timely medical care to address underlying issues and prevent complications.

GLP-1 receptor agonists (GLP-1s), including semaglutide, tirzepatide, and liraglutide, are increasingly used for weight management and show promise for people living with HIV (PLWH). While these medications are generally safe, PLWH may face additional considerations when using them due to how GLP-1s function and interact with antiretroviral therapy (ART). GLP-1s slow gastric emptying and suppress appetite, which may affect ART absorption; gastrointestinal side effects such as nausea or vomiting may also interfere with consistent ART dosing.

Tuberculosis (TB) remains the world’s deadliest infectious disease and a major treatment challenge, especially in cases resistant to standard therapies. A new AI-powered tool developed by Tufts University researchers, called DECIPHAER (Decoding Cross-Modal Information of Pharmacologies via Autoencoders), seeks to advance TB treatment by elucidating exactly how drugs kill the bacterium at the cellular and molecular levels.

Tuberculosis (TB), a contagious bacterial infection primarily affecting the lungs, remains a health risk in the U.S. Though cases declined for decades, recent increases — including ~10,347 cases in early data from 2024 — suggest testing and treatment of latent TB is needed more than ever.  Testing is crucial both for diagnosing latent TB (where bacteria are present but symptoms are absent) and active TB disease (which is contagious and manifests symptoms).

Human papillomavirus (HPV) infects nearly 80% of people at some point during their lives, and while the immune system clears most infections, persistent HPV can lead to genital warts and several cancers (cervical, anal, vulvar, vaginal, penile, and oropharyngeal). HPV vaccination offers strong protection—preventing more than 90% of HPV-related cancers—and is most effective when administered before HPV exposure.

The webpage highlights the disproportionate rates of Hepatitis C virus among American Indian/ Alaska Native communities. This webpage highlights the Cherokee National Health Services acute Hepatitis C virus (HCV) elimination program, which provides community based testing at food distribution centers, universal screening, and rapid point of care diagnostics. Programs such as HCV and Linkage to Program (HELP) use telehealth to connect patients with providers. Project ECHO builds clinical capacity for local practitioners.

This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.